(Q43284727)

English

Fusion protein Ag85B-MPT64(190-198)-Mtb8.4 has higher immunogenicity than Ag85B with capacity to boost BCG-primed immunity against Mycobacterium tuberculosis in mice

scientific article published on 25 August 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

18 November 2017

Fusion protein Ag85B-MPT64(190-198)-Mtb8.4 has higher immunogenicity than Ag85B with capacity to boost BCG-primed immunity against Mycobacterium tuberculosis in mice (English)

1 reference

Europe PubMed Central

18 November 2017

Mycobacterium tuberculosis

1 reference

based on heuristic

inferred from title

author name string

Yu Luo

1

1 reference

Europe PubMed Central

18 November 2017

Bingxiang Wang

2

1 reference

Europe PubMed Central

18 November 2017

Lina Hu

3

1 reference

Europe PubMed Central

18 November 2017

Hongjuan Yu

4

1 reference

Europe PubMed Central

18 November 2017

Zejiao Da

5

1 reference

Europe PubMed Central

18 November 2017

Wenwen Jiang

6

1 reference

Europe PubMed Central

18 November 2017

Nannan Song

7

1 reference

Europe PubMed Central

18 November 2017

Yaqing Qie

8

1 reference

Europe PubMed Central

18 November 2017

Honghai Wang

9

1 reference

Europe PubMed Central

18 November 2017

Zhijiao Tang

10

1 reference

Europe PubMed Central

18 November 2017

Qiaoyang Xian

11

1 reference

Europe PubMed Central

18 November 2017

Ying Zhang

12

1 reference

Europe PubMed Central

18 November 2017

Bingdong Zhu

13

1 reference

Europe PubMed Central

18 November 2017

language of work or name

0 references

publication date

25 August 2009

1 reference

Europe PubMed Central

18 November 2017

1 reference

Europe PubMed Central

18 November 2017

27

1 reference

Europe PubMed Central

18 November 2017

44

1 reference

Europe PubMed Central

18 November 2017

6179-6185

1 reference

Europe PubMed Central

18 November 2017

Focus: Tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.018

7 January 2021

Preventing tuberculosis with bacillus Calmette-Guérin vaccine: a meta-analysis of the literature

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.018

7 January 2021

Current status of TB vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.018

7 January 2021

Frequency of IFN-gamma producing cells correlates with adjuvant enhancement of bacille Calmette-Guèrin induced protection against Mycobacterium bovis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.018

7 January 2021

Protective immunity to tuberculosis with Ag85B-ESAT-6 in a synthetic cationic adjuvant system IC31.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.018

7 January 2021

Selecting the components for a safe and efficient tuberculosis subunit vaccine--recent progress and post-genomic insights

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.018

7 January 2021

Tuberculosis subunit vaccine design: the conflict of antigenicity and immunogenicity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.018

7 January 2021

Use of CpG oligodeoxynucleotides as immune adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.018

7 January 2021

Increased levels of interferon-gamma primed by culture filtrate proteins antigen and CpG-ODN immunization do not confer significant protection against Mycobacterium tuberculosis infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.018

7 January 2021

Chitosan microspheres enhance the immunogenicity of an Ag85B-based fusion protein containing multiple T-cell epitopes of Mycobacterium tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.018

7 January 2021

Current progress in tuberculosis vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.018

7 January 2021

Expression and purification of Mycobacterium tuberculosis ESAT-6 and MPT64 fusion protein and its immunoprophylactic potential in mouse model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.018

7 January 2021

The protective effect of the Mycobacterium bovis BCG vaccine is increased by coadministration with the Mycobacterium tuberculosis 72-kilodalton fusion polyprotein Mtb72F in M. tuberculosis-infected guinea pigs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.018

7 January 2021

Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guérin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.018

7 January 2021

Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in Mycobacterium tuberculosis-infected individuals

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.018

7 January 2021

T-cell recognition of Mycobacterium tuberculosis culture filtrate fractions in tuberculosis patients and their household contacts

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.018

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2009.08.018

1 reference

Europe PubMed Central

18 November 2017

1 reference

Europe PubMed Central

18 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43284727&oldid=1985572298"